Search your symptoms with MEDgle. You can check your symptoms. It is a medical symptom search allowing you find out what options make sense for you.
CLOSE
PATIENT GPS
病人
healthcare providers
how it works
有关
login
编辑搜索
新的搜索
症状
诊断
医生
药品
程序
close
症状
诊断
药物
程序
医生
symptom 持续时间
0-3天
4-14天
2周,2个月
2-6个月
6个月+
add symptom to current symptom search
同上
0-3天
4-14天
2周,2个月
2-6个月
6个月+
add symptom to current symptom search
同上
0-3天
4-14天
2周,2个月
2-6个月
6个月+
add symptom to current symptom search
同上
0-3天
4-14天
2周,2个月
2-6个月
6个月+
性别
男性
女性
年龄
1-3
4-11
12-17
18-29
30-50
50+
年龄
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
calculate
visual
[hide visual search]
search visually
症状
|
诊断
|
药物
|
程序
|
医生
搜索症状
•
寻找你的症状的原因
•
医师发现相关的类型
搜索诊断
•
了解详情的诊断
•
了解有关的测试和治疗
•
在网路上寻找有用的资源
搜索毒品
•
了解不同的治疗药物
•
了解它们是什么用途
•
知道的可能选择
查寻医疗过程
•
了解不同的诊断和治疗程序
•
了解它们是什么用途
•
知道的可能选择
搜索医师
•
查找您所在地区的医师
•
了解他们做什么
•
得到正确的帮助您的需要
alemtuzumab
从减少的结果
147 billion
206 million
5 million
63420
to ~240 options
options split into images, definition, symptoms, related diagnoses, diagnostic tests, therapies, and medications
什么是 'alemtuzumab'?
定义 Alemtuzumab - Alemtuzumab
Alemtuzumab (marketed as Campath , MabCampath or Campath-1H ) is a monoclonal antibody used in the treatment of chronic lymphocytic leukemia (CLL) and T-cell lymphoma .
Alemtuzumab targets CD52 , a protein present on the surface of mature lymphocytes , but not on the stem cells from which these lymphocytes were derived.
更多
Alemtuzumab (marketed as Campath , MabCampath or Campath-1H ) is a monoclonal antibody used in the treatment of chronic lymphocytic leukemia (CLL) and T-cell lymphoma .
Alemtuzumab targets CD52 , a protein present on the surface of mature lymphocytes , but not on the stem cells from which these lymphocytes were derived. It is used as second line therapy for CLL. It was approved by the Food and Drug Administration for patients who have been treated with alkylating agents and who have failed fludarabine therapy.
less
diagnoses treated with 'alemtuzumab'
1 - 5 of
5
诊断
慢性淋巴细胞白血病
cancer of white blood cells
在网上搜索:
Alemtuzumab 和 慢性淋巴细胞白血病
转移
spread of malignant tumors to other body sites
在网上搜索:
Alemtuzumab 和 转移
恶性肿瘤
cancer
在网上搜索:
Alemtuzumab 和 恶性肿瘤
移植物抗宿主反应
complication of organ transplantation
在网上搜索:
Alemtuzumab 和 移植物抗宿主反应
hypereosinophilic综合征
multisystem disease from increase in a type of white blood cell
在网上搜索:
Alemtuzumab 和 hypereosinophilic综合征
related procedures when taking 'alemtuzumab'
1 - 5 of
151
程序
胸部CT表现
在网上搜索:
Alemtuzumab 和 胸部CT表现
CT扫描
在网上搜索:
Alemtuzumab 和 CT扫描
全血球计数
在网上搜索:
Alemtuzumab 和 全血球计数
中央静脉导管
在网上搜索:
Alemtuzumab 和 中央静脉导管
超声提示中央静脉导管
在网上搜索:
Alemtuzumab 和 超声提示中央静脉导管
腹部CAT扫描
在网上搜索:
Alemtuzumab 和 腹部CAT扫描
骨盆的CT
在网上搜索:
Alemtuzumab 和 骨盆的CT
染色体分析
在网上搜索:
Alemtuzumab 和 染色体分析
血清免疫球蛋白
在网上搜索:
Alemtuzumab 和 血清免疫球蛋白
腹部磁共振成像
MRI of abdominal contents
在网上搜索:
Alemtuzumab 和 腹部磁共振成像
脑脊髓液分析
在网上搜索:
Alemtuzumab 和 脑脊髓液分析
脑脊液开启压力
在网上搜索:
Alemtuzumab 和 脑脊液开启压力
化疗
Use of chemical substances to treat disease
在网上搜索:
Alemtuzumab 和 化疗
Cytodiagnosis
在网上搜索:
Alemtuzumab 和 Cytodiagnosis
流式细胞仪
在网上搜索:
Alemtuzumab 和 流式细胞仪
免疫细胞化学
在网上搜索:
Alemtuzumab 和 免疫细胞化学
免疫治疗
在网上搜索:
Alemtuzumab 和 免疫治疗
腰椎穿刺
在网上搜索:
Alemtuzumab 和 腰椎穿刺
淋巴结活检
在网上搜索:
Alemtuzumab 和 淋巴结活检
磁共振成像
在网上搜索:
Alemtuzumab 和 磁共振成像
欲了解更多请登录,登录是免费的(点击登陆)
related medication for 'alemtuzumab'
1 - 5 of
84
药物
chlorambucil
在网上搜索:
Alemtuzumab 和 chlorambucil
rituximab
在网上搜索:
Alemtuzumab 和 rituximab
vincristine
在网上搜索:
Alemtuzumab 和 vincristine
cyclophosphamide
在网上搜索:
Alemtuzumab 和 cyclophosphamide
doxorubicin
在网上搜索:
Alemtuzumab 和 doxorubicin
fludarabine
在网上搜索:
Alemtuzumab 和 fludarabine
methotrexate
在网上搜索:
Alemtuzumab 和 methotrexate
thalidomide
在网上搜索:
Alemtuzumab 和 thalidomide
5-fluorouracil (5-fu)
在网上搜索:
Alemtuzumab 和 5-fluorouracil (5-fu)
6-mercaptopurine (6-mp)
在网上搜索:
Alemtuzumab 和 6-mercaptopurine (6-mp)
actinomycin-d
在网上搜索:
Alemtuzumab 和 actinomycin-d
alkylating agents
在网上搜索:
Alemtuzumab 和 alkylating agents
altretamine
在网上搜索:
Alemtuzumab 和 altretamine
anastrozole
在网上搜索:
Alemtuzumab 和 anastrozole
anti tumor antibiotics
在网上搜索:
Alemtuzumab 和 anti tumor antibiotics
antimetabolites
在网上搜索:
Alemtuzumab 和 antimetabolites
arsenic trioxide
在网上搜索:
Alemtuzumab 和 arsenic trioxide
bevacizumab
在网上搜索:
Alemtuzumab 和 bevacizumab
bexarotene
在网上搜索:
Alemtuzumab 和 bexarotene
bicalutamide
在网上搜索:
Alemtuzumab 和 bicalutamide
欲了解更多请登录,登录是免费的(点击登陆)
以下是类型的医生有关 'Alemtuzumab'.
related types of physicians 'family practitioner, internist, oncologist'
show local physicians
郵政編碼
找到的地方
星級代表沒有相關的專題評價
更多
結果表明,電腦產生的建議,以幫助您找到一個醫生. MEDgle不推薦任何特定類型的醫生或聲稱是完整或準確的供應商和專業建議.
网络搜索结果 'alemtuzumab'?
结果
1 - 50
- Alemtuzumab
Alemtuzumab - Wikipedia, the free encyclopedia
[
翻译此页
]
Alemtuzumab is also used in some conditioning regimens for bone marrow ... Afutuzumab, Alemtuzumab, Bevacizumab/Ranibizumab, Bivatuzumab mertansine, ...
http://en.wikipedia.org/wiki/Alemtuzumab
en.wikipedia.org
-
summary
Alemtuzumab
[
翻译此页
]
Drug details for Alemtuzumab. ... Alemtuzumab may be used by itself or in combination with other drugs to treat ... Alemtuzumab is sometimes used in clinical ...
http://www.webmd.com/cancer/alemtuzumab
www.webmd.com
-
summary
ALEMTUZUMAB - INJECTABLE (Campath) side effects, medical uses, and drug ...
[
翻译此页
]
Read more about the prescription drug ALEMTUZUMAB - INJECTABLE. ... WARNING: Infrequently, alemtuzumab may cause serious (sometimes fatal) side ...
http://www.medicinenet.com/alemtuzumab-injectable/article.htm
www.medicinenet.com
-
summary
Alemtuzumab - Yahoo! Health
[
翻译此页
]
Before receiving alemtuzumab, tell your doctor if you have heart disease, a ... What is the most important information I should know about alemtuzumab? ...
http://health.yahoo.com/leukemia-medications/alemtuzumab/hea...
health.yahoo.com
-
summary
alemtuzumab medical facts from Drugs.com
[
翻译此页
]
Physician reviewed alemtuzumab patient information - includes alemtuzumab description, dosage and directions. ... 6 months after you stop using alemtuzumab. ...
http://www.drugs.com/mtm/alemtuzumab.html
www.drugs.com
-
summary
MedlinePlus Drug Information: Alemtuzumab Injection
[
翻译此页
]
Alemtuzumab injection may cause a decrease in the number of blood cells made by ... At first, alemtuzumab injection is usually given in gradually increasing doses ...
http://www.nlm.nih.gov/medlineplus/druginfo/meds/a608053.html
www.nlm.nih.gov
-
summary
Alemtuzumab in chronic lymphocytic leukemia
[
翻译此页
]
What toxicities are associated with the use of alemtuzumab? Which patients are more likely?or less likely?to benefit from treatment with alemtuzumab? ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1899355
www.pubmedcentral.nih.gov
-
summary
Alemtuzumab (Intravenous Route) - MayoClinic.com
[
翻译此页
]
Mayo Clinic offers award-winning medical and health information and tools for healthy living. ... Alemtuzumab is a monoclonal antibody. ...
http://www.mayoclinic.com/health/drug-information/DR601635/METHOD=print
www.mayoclinic.com
-
summary
Campath (Alemtuzumab) Drug Information: Uses, Side Effects, Drug ...
[
翻译此页
]
Learn about the prescription medication Campath (Alemtuzumab), drug uses, dosage, side effects, drug interactions, warnings, and patient labeling.
http://www.rxlist.com/campath-drug.htm
www.rxlist.com
-
summary
Mycobacterium haemophilum Infection after Alemtuzumab Treatment | CDC EID
[
翻译此页
]
Alemtuzumab causes profound and prolonged lymphocyte depletion, which ... Immediately before receiving alemtuzumab, he had been given rituximab for 3 months. ...
http://www.cdc.gov/eid/content/14/11/1821.htm
www.cdc.gov
-
summary
Alemtuzumab: Drug Information Provided by Lexi-Comp: Merck Manual ...
[
翻译此页
]
Alemtuzumab: Reports of Infection-Related Fatalities - November 2008 ... Use of alemtuzumab as consolidation therapy is presently not approved in Canada. ...
http://www.merck.com/mmpe/print/lexicomp/alemtuzumab.html
www.merck.com
-
summary
Definition of alemtuzumab - NCI Dictionary of Cancer Terms
[
翻译此页
]
The Nation's Investment in Cancer Research FY 2010 ... alemtuzumab. A type of monoclonal antibody used in the treatment of leukemia. ...
http://www.nci.nih.gov/Templates/db_alpha.aspx?CdrID=44851
www.nci.nih.gov
-
summary
Discovery Health :: Drug Reference :: Select Drug
[
翻译此页
]
Get the scoop on the interaction between the drugs that you select to test against. ... Alemtuzumab can lower the blood cells that help your body fight infections. ...
http://health.discovery.com/webapps/drugreference.do?drug=41388&pagetype=results
health.discovery.com
-
summary
Clinical Study: 05-H-0242, A Pilot Study of Alemtuzumab (Campath) in ...
[
翻译此页
]
Clinical Study Summary Sheet for 05-H-0242 ... Because alemtuzumab destroys lymphocytes, it may be effective in treating aplastic anemia. ...
http://clinicalstudies.info.nih.gov/detail/A_2005-H-0242.html
clinicalstudies.info.nih.gov
-
summary
Alemtuzumab facts and comparsions at Drugs.com
[
翻译此页
]
All about Alemtuzumab. View complete and up to date Alemtuzumab information - part of the Drugs.com trusted medication database.
http://www.drugs.com/cdi/alemtuzumab.html
www.drugs.com
-
summary
Aplastic Anemia - Evaluation, Treatment and Research at the National ...
[
翻译此页
]
The National Heart, Lung and Blood Institute is actively seeking patients with ... Alemtuzumab (Campath) for Refractory or Relapsed Severe Aplastic Anemia ...
http://patientrecruitment.nhlbi.nih.gov/AplasticAnemia.aspx
patientrecruitment.nhlbi.nih.gov
-
summary
Drug Information for Alemtuzumab IV - WebMD
[
翻译此页
]
Find medical information for Alemtuzumab IV including side effects, drug interactions, images and pictures, medication uses, warnings, user ratings and reviews.
http://www.webmd.com/drugs/drug-21057-Alemtuzumab%20IV.aspx?...
www.webmd.com
-
summary
Phase II study of alemtuzumab in chronic lymphoproliferative disorders.
[
翻译此页
]
Alemtuzumab was given intravenously at doses of 3 mg, 10 mg, and 30 mg on 3 ... CONCLUSIONS: Alemtuzumab has a high response rate in patients with chronic ...
http://www.ncbi.nlm.nih.gov/pubmed/12910522
www.ncbi.nlm.nih.gov
-
summary
Alemtuzumab - Yahoo! Health
[
翻译此页
]
Alemtuzumab is a monoclonal antibody that attaches itself to a protein called CD52. ... Alemtuzumab may be used by itself or in combination with other drugs to treat ...
http://health.yahoo.com/leukemia-medications/alemtuzumab/healthwise--tv7623.html
health.yahoo.com
-
summary
R. equi Infection after Alemtuzumab Therapy | CDC EID
[
翻译此页
]
Alemtuzumab, an anti-CD52 monoclonal antibody, causes ... Infectious complications associated with alemtuzumab use for lymphoproliferative disorders. ...
http://www.cdc.gov/eid/content/13/12/1942.htm
www.cdc.gov
-
summary
ALEMTUZUMAB - INJECTABLE (Campath) side effects, medical uses, and drug ...
[
翻译此页
]
Read doctor-produced health and medical information written for you to make informed decisions about ... View All 5 alemtuzumab-injectable Doctor's & Expert's ...
http://www.medicinenet.com/alemtuzumab-injectable/index.htm
www.medicinenet.com
-
summary
Sunitinib - Wikipedia, the free encyclopedia
[
翻译此页
]
Description of targeted therapy drug includes indications for therapy ... myeloid: CD52 (Alemtuzumab) L+M: CD33 (Gemtuzumab) Tyrosine kinase inhibitors ("-nib" ...
http://en.wikipedia.org/wiki/Sunitinib
en.wikipedia.org
-
summary
Chronic Lymphocytic Leukemia (CLL): Leukemias: Merck Manual Home Edition
[
翻译此页
]
Introduction· Acute Lymphocytic Leukemia (ALL)· Acute Myelocytic Leukemia (AML) ... or alemtuzumab Some Trade Names. CAMPATH ) are considered. ...
http://www.merck.com/mmhe/sec14/ch176/ch176d.html
www.merck.com
-
summary
Pharmacokinetics of alemtuzumab in combination with fludarabine in ...
[
翻译此页
]
Following alemtuzumab dose escalation (3 to 10 to 30 mg over three days) ... Plasma concentrations of alemtuzumab were determined using the previously ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2625426
www.pubmedcentral.nih.gov
-
summary
Alemtuzumab consumer information from Drugs.com
[
翻译此页
]
Alemtuzumab patient information. ... Pregnancy?Alemtuzumab may cause harm to the fetus when ... You should avoid becoming pregnant while receiving alemtuzumab. ...
http://www.drugs.com/cons/Alemtuzumab.html
www.drugs.com
-
summary
Cytomegalovirus retinitis after hematopoietic stem cell transplantation ...
[
翻译此页
]
Cytomegalovirus retinitis after hematopoietic stem cell transplantation with alemtuzumab. ... transplantation (HSCT) using an alemtuzumab-based (Campath-1H, Genzyme, ...
http://www.ncbi.nlm.nih.gov/pubmed/18562004
www.ncbi.nlm.nih.gov
-
summary
Guarded Optimism for Experimental MS Drug - Neurology (Brain and Nerve ...
[
翻译此页
]
Explains neurology (brain and nerve) conditions; includes symptoms, causes, ... He agrees that alemtuzumab's role in MS treatment remains to be determined. ...
http://www.medicinenet.com/guide.asp?s=rss&a=93604&k=interferon_Specialty
www.medicinenet.com
-
summary
Bevacizumab - Wikipedia, the free encyclopedia
[
翻译此页
]
myeloid: CD52 (Alemtuzumab) L+M: CD33 (Gemtuzumab) Tyrosine kinase inhibitors ("-nib" ... Afutuzumab, Alemtuzumab, Bevacizumab/Ranibizumab, Bivatuzumab mertansine, ...
http://en.wikipedia.org/wiki/Bevacizumab
en.wikipedia.org
-
summary
Population pharmacokinetics?pharmacodynamics of alemtuzumab (Campath ...
[
翻译此页
]
Alemtuzumab pharmacokinetics were best characterized by a two-compartment model ... Alemtuzumab is currently administered as a 2-h intravenous infusion under a dose ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2000651
www.pubmedcentral.nih.gov
-
summary
Combination therapy with fludarabine and rituximab followed by ...
[
翻译此页
]
Toxicity with alemtuzumab included infusion-related toxicity, myelosuppression, ... The generalized use of alemtuzumab as consolidation therapy cannot yet be ...
http://www.ncbi.nlm.nih.gov/pubmed/18189296?ordinalpos=3&ito...
www.ncbi.nlm.nih.gov
-
summary
Drugs A-Z List - A on RxList
[
翻译此页
]
Browse an A-Z list of Brand and Generic drugs to learn about your prescription medication. ... Alemtuzumab (Campath) Alendronate Sodium (Fosamax) ...
http://www.rxlist.com/drugs/alpha_a.htm
www.rxlist.com
-
summary
Therapies under investigation for multiple sclerosis - Wikipedia, the ...
[
翻译此页
]
Therefore, all patients receiving alemtuzumab should have their platelet count ... Information from GenZyme on its clinical trial for Alemtuzumab ...
http://en.wikipedia.org/wiki/Therapies_under_investigation_f...
en.wikipedia.org
-
summary
alimta and Alemtuzumab Drug Interactions
[
翻译此页
]
alimta and Alemtuzumab Drug Interactions. Drug-drug and drug-food interactions between alimta and Alemtuzumab ... Alemtuzumab alone may cause severe and ...
http://www.drugs.com/drug-interactions/alimta_d05047_alemtuzumab_d04756.html
www.drugs.com
-
summary
Chronic lymphocytic leukemia (CLL)
[
翻译此页
]
Chronic lymphocytic leukemia is a (cancer) of the white blood cells (lymphocytes) characterized by a slow, progressive ... drug alemtuzumab (Campath), which ...
http://adam.about.com/encyclopedia/000532trt.htm?terms=chron...
adam.about.com
-
summary
Drug Information for M-R-Vax II SubQ - WebMD
[
翻译此页
]
Find medical information for M-R-Vax II SubQ including side effects, drug interactions, ... LIVE VIRAL VACCINES/ALEMTUZUMAB. LIVE VACCINES/ANAKINRA; RILONACEPT ...
http://www.webmd.com/drugs/drug-9298-M-R-Vax+II+SubQ.aspx?dr...
www.webmd.com
-
summary
Health Encyclopedia from A to Z on Yahoo! Health
[
翻译此页
]
Health encyclopedia of diseases and conditions covering signs, symptoms, causes, incidence, risk, prevention, tests, diagnosis, treatment, complications and side effects.
http://health.yahoo.com/ency/
health.yahoo.com
-
summary
Alemtuzumab in the up-front setting.
[
翻译此页
]
Alemtuzumab is a humanized chimeric monoclonal antibody targeting CD52. ... Early trials showed alemtuzumab's value in refractory disease and helped to ...
http://www.ncbi.nlm.nih.gov/pubmed/18728844?ordinalpos=1&ito...
www.ncbi.nlm.nih.gov
-
summary
Clinical Study: 03-H-0249, A Randomized Trial of Immunosupression in ...
[
翻译此页
]
Clinical Study Summary Sheet for 03-H-0249 ... Drug: Alemtuzumab (Campath-1H) Drug: Thymoglobulin (r-ATG) Drug: Cyclosporine (CsA) ...
http://clinicalstudies.info.nih.gov/cgi/detail.cgi?A_2003-H-0249.html
clinicalstudies.info.nih.gov
-
summary
Imatinib - Wikipedia, the free encyclopedia
[
翻译此页
]
Imatinib. From Wikipedia, the free encyclopedia (Redirected from Glivec) ... Tositumomab) · other (Alemtuzumab, Bevacizumab, Edrecolomab, Gemtuzumab) ...
http://en.wikipedia.org/wiki/Glivec
en.wikipedia.org
-
summary
Drugs.com | Drug Interactions Checker
[
翻译此页
]
Drug Interaction Checker. Check for drug-drug and drug-food interactions ... Browse all medications A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ...
http://www.drugs.com/data/channel/md/drkoop.cfm?int=2&list=1...
www.drugs.com
-
summary
Prolymphocytic leukemia.
[
翻译此页
]
With the introduction of alemtuzumab, most patients who progressed despite ... We recommend alemtuzumab as initial therapy and offer stem cell transplant (SCT) ...
http://www.ncbi.nlm.nih.gov/pubmed/15869731
www.ncbi.nlm.nih.gov
-
summary
Drug Information for Measles Virus Vaccine SubQ - WebMD
[
翻译此页
]
Find medical information for Measles Virus Vaccine SubQ including side effects, drug ... LIVE VIRAL VACCINES/ALEMTUZUMAB. LIVE VACCINES/ANAKINRA; RILONACEPT ...
http://www.webmd.com/drugs/drug-8804-Measles%20Virus%20Vacci...
www.webmd.com
-
summary
Definition of alemtuzumab - National Cancer Institute Drug Dictionary
[
翻译此页
]
The Nation's Investment in Cancer Research FY 2010 ... alemtuzumab ... Alemtuzumab is an IgG1 kappa with human variable framework and constant regions, ...
http://wwwicic.nci.nih.gov/Templates/drugdictionary.aspx?CdrID=37783
wwwicic.nci.nih.gov
-
summary
Milatuzumab - Wikipedia, the free encyclopedia
[
翻译此页
]
STATEMENT ON A NONPROPRIETARY NAME ADOPTED BY THE USAN COUNCIL - MILATUZUMAB, ... Afutuzumab, Alemtuzumab, Bevacizumab/Ranibizumab, Bivatuzumab mertansine, ...
http://en.wikipedia.org/wiki/Milatuzumab
en.wikipedia.org
-
summary
Neoplasia: Targeting CD37-positive lymphoid malignancies with a novel ...
[
翻译此页
]
Alemtuzumab was produced by Ilex Pharmaceuticals (San Antonio, TX) and purchased ... Ability of trastuzumab, CD37-SMIP, alemtuzumab, or rituximab to mediate ADCC was ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1988922
www.pubmedcentral.nih.gov
-
summary
Rituximab and alemtuzumab induce a nonclassic, caspase-independent ...
[
翻译此页
]
The monoclonal antibodies (MoAbs) alemtuzumab (anti-CD52) and rituximab (anti ... Both alemtuzumab and rituximab also killed freshly isolated CLL cells, with a ...
http://www.ncbi.nlm.nih.gov/pubmed/15309525?ordinalpos=1&ito...
www.ncbi.nlm.nih.gov
-
summary
Drugs A-Z List - C on RxList
[
翻译此页
]
Browse an A-Z list of Brand and Generic drugs to learn about your prescription medication. ... Campath (Alemtuzumab) Campral (Acamprosate Calcium) ...
http://www.rxlist.com/drugs/alpha_c.htm
www.rxlist.com
-
summary
Smallpox Vaccine (Injection Route) - MayoClinic.com
[
翻译此页
]
Mayo Clinic offers award-winning medical and health information and ... Alemtuzumab. Altretamine. Amonafide. Amsacrine. Asparaginase. Azacitidine. Azathioprine ...
http://www.mayoclinic.com/health/drug-information/DR602529/METHOD=print
www.mayoclinic.com
-
summary
MedlinePlus Drug Information: Drugs beginning with Ca
[
翻译此页
]
Caduet® (as a combination product containing Amlodipine and Atorvastatin) see Amlodipine ... Campath® see Alemtuzumab Injection ...
http://www.nlm.nih.gov/medlineplus/druginfo/drug_Ca.html
www.nlm.nih.gov
-
summary
Camptothecin - Wikipedia, the free encyclopedia
[
翻译此页
]
Camptothecin (CPT) is a cytotoxic quinoline alkaloid which inhibits the DNA ... Tositumomab) · other (Alemtuzumab, Bevacizumab, Edrecolomab, Gemtuzumab) ...
http://en.wikipedia.org/wiki/Camptothecins
en.wikipedia.org
-
summary
显示更多
1
2
Chat with eNurse Kim about 'Alemtuzumab' or something else!
快览
related diagnosis category
oncology
血液学
皮肤科
胃肠
免疫系统
常见问题解答/关于
|
免责声明
|
隐私权政策
|
服务条款
|
浏览
|
beta
|
联系
|
API - Catalyst
MEDgle does not provide medical advice, diagnosis or treatment. Copyright 2006-2012, MEDgle Inc. All Rights Reserved. MEDgle is NOT affiliated with Google. Last Updated: Mar 14, 2012
我们遵循健康网络基金会的
医学和健康网站的行为准则
.
点击这里核实
.
Invited Sponsor for Communications Conference
Finalist -- search & reference
MEDgle已被选定为2009年的企业奖最佳的医学研究